Trial Profile
Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in cystic fibrosis patients and healthy controls
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Azithromycin (Primary) ; Clarithromycin (Primary) ; Ivacaftor (Primary) ; Ritonavir (Primary)
- Indications Cystic fibrosis; Exocrine pancreatic insufficiency
- Focus Pharmacokinetics
- Acronyms IACI
- 06 Jun 2018 New trial record